Your browser doesn't support javascript.
loading
Role of Radioembolization in Metastatic Neuroendocrine Tumors.
Lewandowski, Robert J; Toskich, Beau B; Brown, Daniel B; El-Haddad, Ghassan; Padia, Siddharth A.
Afiliación
  • Lewandowski RJ; Northwestern University, 676 N. St Clair, Suite 800, Chicago, IL, 60611, USA. r-lewandowski@northwestern.edu.
  • Toskich BB; Mayo Clinic Florida, Jacksonville, FL, USA.
  • Brown DB; Division of Interventional Radiology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • El-Haddad G; Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Padia SA; Division of Interventional Radiology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
Cardiovasc Intervent Radiol ; 45(11): 1590-1598, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35918431
The liver is the most common site of metastasis for neuroendocrine tumors originating from the gastrointestinal tract. Neuroendocrine liver metastases (NELMs) portend a worsening clinical course, making local management important. Local treatment options include surgery, thermal ablation, and trans-catheter intra-arterial therapies, such as radioembolization. Radioembolization is generally preferred over other embolotherapies in patients with colonized biliary systems. Current best practice involves personalized treatment planning, optimizing tumor radiation absorbed dose and minimizing radiation to the normal hepatic parenchyma. As part of a multidisciplinary approach, radioembolization is a versatile embolotherapy offering neoadjuvant, palliative, and ablative treatment options for patients with NELMs.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Braquiterapia / Tumores Neuroendocrinos / Embolización Terapéutica / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Braquiterapia / Tumores Neuroendocrinos / Embolización Terapéutica / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos